JCICX
Price
$67.75
Change
-$2.87 (-4.06%)
Updated
Apr 10 closing price
Net Assets
1.63B
RGAFX
Price
$66.13
Change
-$2.72 (-3.95%)
Updated
Apr 10 closing price
Net Assets
271.59B
Ad is loading...

JCICX vs RGAFX

Header iconJCICX vs RGAFX Comparison
Open Charts JCICX vs RGAFXBanner chart's image
JPMorgan U.S. GARP Equity C
Price$67.75
Change-$2.87 (-4.06%)
VolumeN/A
Net Assets1.63B
American Funds Growth Fund of Amer R5
Price$66.13
Change-$2.72 (-3.95%)
VolumeN/A
Net Assets271.59B
JCICX vs RGAFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JCICX vs. RGAFX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCICX is a Buy and RGAFX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAFX has more cash in the bank: 272B vs. JCICX (1.64B). RGAFX pays higher dividends than JCICX: RGAFX (0.66) vs JCICX (0.00). JCICX was incepted earlier than RGAFX: JCICX (20 years) vs RGAFX (23 years). JCICX (1.42) is less costly to investors than RGAFX (0.34). JCICX is a more actively managed with annual turnover of: 46.00 vs. RGAFX (25.00). RGAFX has a lower initial minimum investment than JCICX: RGAFX (250) vs JCICX (1000). JCICX annual gain was more profitable for investors over the last year : -0.97 vs. RGAFX (-1.74). RGAFX return over 5 years is better than : 52.56 vs. JCICX (46.52).
JCICXRGAFXJCICX / RGAFX
Total Expense Ratio1.340.34394%
Annual Report Gross Expense Ratio1.420.34418%
Fund Existence20 years23 years-
Gain YTD-10.562-7.485141%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.64B272B1%
Annual Yield % from dividends0.000.66-
Returns for 1 year-0.97-1.7456%
Returns for 3 years23.449.85238%
Returns for 5 years46.5252.5688%
Returns for 10 years75.6256.31134%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIMD0.520.02
+3.63%
Ainos
IKT1.86-0.03
-1.59%
Inhibikase Therapeutics
TRIN13.81-0.36
-2.54%
Trinity Capital
JBL132.04-5.34
-3.89%
Jabil
USAC22.94-1.19
-4.93%
USA Compression Partners LP